USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Vital Signs - Prescription Drugs Under Medicare Part D - A Current Perspective
Vital Signs - Prescription Drugs Under Medicare Part D - A Current Perspective
RELEASE DATE
08-Oct-2007
08-Oct-2007
REGION
North America
North America
Research Code: 9561-00-45-00-00
SKU: HC00501-NA-MR_03973
$1,500.00
Special Price $1,125.00 save 25 %
In stock
SKU
HC00501-NA-MR_03973
Description
This issue of Vital Signs, released on October 8, 2007, provides a strategic overview of the impact of Medicare Part D on beneficiaries and pharmaceutical companies. Additionally, a company spotlight is provided for pSivida Limited, a global drug delivery company. Reimbursement and regulatory news from the FDA is also provided for the week of September 24 - September 28, 2007.
Table of Contents
This week's issue:
Popular Topics
This issue of Vital Signs, released on October 8, 2007, provides a strategic overview of the impact of Medicare Part D on beneficiaries and pharmaceutical companies. Additionally, a company spotlight is provided for pSivida Limited, a global drug delivery company. Reimbursement and regulatory news from the FDA is also provided for the week of September 24 - September 28, 2007.
| No Index | Yes |
|---|---|
| Podcast | No |
| Industries | Healthcare |
| WIP Number | 9561-00-45-00-00 |
| Is Prebook | No |